Zylox-Tonbridge Medical Technology Co., Ltd.

HKEX:2190.HK

10.92 (HKD) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Revenue 182.995182.995148.812148.812115.066115.06690.67490.67476.37276.37253.21453.21435.74235.74212.76212.7621.0541.054
Cost of Revenue 52.53952.53941.64141.64129.74329.74322.07822.07818.63318.63313.33613.3369.689.684.9084.9080.7650.765
Gross Profit 130.457130.457107.171107.17185.32385.32368.59668.59657.73957.73939.87939.87926.06226.0627.8547.8540.290.29
Gross Profit Ratio 0.7130.7130.720.720.7420.7420.7570.7570.7560.7560.7490.7490.7290.7290.6150.6150.2750.275
Reseach & Development Expenses 50.77150.77165.10465.10465.40365.40369.71169.71147.0247.0259.56159.56124.4924.4922.30522.30513.72813.728
General & Administrative Expenses 21.79621.79631.86531.86525.17925.17930.02730.02724.64224.64223.21823.21827.08227.08211.91811.9183.5793.579
Selling & Marketing Expenses 39.99139.99144.44444.44437.4737.4743.40343.40326.66626.66634.76134.76112.87412.8747.7887.7882.4392.439
SG&A 61.78761.78776.31776.31762.64962.64973.44273.44251.30851.30857.98957.98939.95639.95619.70519.7056.0186.018
Other Expenses -0.401-0.4016.946000000000000000
Operating Expenses 112.157112.157148.366148.366122.39122.39142.107142.10788.42788.427110.16110.1662.01962.01940.71940.71917.50617.506
Operating Income 18.318.3-41.195-32.514-41.066-41.066-72.962-72.962-38.794-38.794-70.928-70.928-38.155-38.155-30.998-30.998-17.673-17.673
Operating Income Ratio 0.10.1-0.277-0.218-0.357-0.357-0.805-0.805-0.508-0.508-1.333-1.333-1.068-1.068-2.429-2.429-16.767-16.767
Total Other Income Expenses Net 16.13316.13319.4410.75823.45423.45428.93728.93726.04226.0425.9425.9423.2973.2970.0310.0310.2730.273
Income Before Tax 34.43334.433-21.756-21.756-17.612-17.612-44.026-44.026-12.752-12.752-64.986-64.986-34.859-34.859-32.834-32.834-17.4-17.4
Income Before Tax Ratio 0.1880.188-0.146-0.146-0.153-0.153-0.486-0.486-0.167-0.167-1.221-1.221-0.975-0.975-2.573-2.573-16.509-16.509
Income Tax Expense 3.8373.8370.1460.1460.1460.146-000000000000
Net Income 34.43334.433-21.61-21.61-17.757-17.757-44.026-44.026-12.752-12.752-64.986-64.986-34.859-34.859-32.834-32.834-17.4-17.4
Net Income Ratio 0.1880.188-0.145-0.145-0.154-0.154-0.486-0.486-0.167-0.167-1.221-1.221-0.975-0.975-2.573-2.573-16.509-16.509
EPS 0.110.11-0.066-0.066-0.054-0.054-0.13-0.13-0.039-0.039-0.2-0.2-0.13-0.13-0.16-0.16-0.095-0.095
EPS Diluted 0.110.11-0.066-0.066-0.054-0.054-0.13-0.13-0.039-0.039-0.2-0.2-0.13-0.13-0.16-0.16-0.095-0.095
EBITDA 29.94229.942-24.443-24.443-34.581-34.581-67.253-67.253-34.485-34.485-68.183-68.183-36.06-36.06-29.512-29.512-15.85-15.85
EBITDA Ratio 0.1640.164-0.164-0.164-0.301-0.301-0.742-0.742-0.452-0.452-1.281-1.281-1.009-1.009-2.313-2.313-15.038-15.038